White Paper

Formulation Considerations For Over-Encapsulation Of Clinical Trial Materials In DBcaps® Capsules

Source: Capsugel® | Lonza Pharma & Biotech

This paper provides a technical review of formulation considerations relating to the use of gelatin DBcaps capsules for clinical trials, as well as a list of published references. Submitted by Capsugel

access the White Paper!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Pharmaceutical Online

Please tell us more about you so that we can customize our newsletters to your specific interests: